June 7th 2025
The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.
Cancer's Toll Beyond the Disease: Medical Costs and Productivity
Rivaroxaban Safe and Effective in Cancer Patients With Thrombosis
OB-GYN Groups Say Insurers' Genetic Testing Rules Limit Access to Care